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Fig. S1. vSlfn does not inhibit RNA virus-induced IFNβ or NF-κB reporter activation. (A-
C) HEK293T cells expressing firefly luciferase under the control of the IFNβ (A) or NF-κB (B-
C) promoters were transfected with vectors encoding vSlfn or VACV virus proteins C6 and A49, 
or the corresponding empty vector as controls. C6 and A49 are known inhibitors of IRF3 and 
NF-κB signaling included here as controls. (A) 24 h post-transfection, cells were infected or not 
with Sendai virus 1 and luciferase activity measured at 24 hpi. (B) Similarly, cells were 
stimulated or not with interleukin (IL)-1β for 8 h before luciferase activity determination. (C) 
Cells were transfected as above and simultaneously transfected with TNF receptor associated 
factor 6 (TRAF6). After 16 h, luciferase activity was determined. In all cases, luciferase activity 
was measured, normalized and presented as a fold increase over unstimulated EV-transfected 
cells. Data are presented as mean ± SD and represent one of at least three experiments performed 
in triplicate. ***, p < 0.001 (unpaired Student’s t test comparing with empty vector). (D) 
Expression of FLAG-tagged versions of vSlfn. HEK293T cells were independently transfected 
with expression vectors encoding full-length vSlfn, vSlfn lacking p26 domain (vSlfn∆p26) or 
p26 domain, fused with a C-terminal 3xFLAG epitope. Whole cell lysates were analyzed 24 h 








Fig. S2. Absence of vSlfn expression in ECTV∆vSlfn infected cells. (A) Analysis of vSlfn 
expression by western blot in BSC-1 cells after infection with 5 pfu/cell of ECTV-WT and 
ECTV∆vSlfn at the indicated times post-infection. (B) Analysis of vSlfn and vSlfn∆p26 
expression from recombinant ECTVs expressing C-terminally Strep-Tag tagged versions of 
vSlfn∆p26 and full length vSlfn (ECTV-vSlfn∆p26StrepTag and ECTV-vSlfnStrepTag, 
respectively). BSC-1 cells were infected as above and lysates analyzed by immunoblotting using 
an anti-StrepTag antibody at 24 hpi, confirming expression of vSlfn∆p26. ECTV protein CrmD 
was used as control of infection and β-actin as protein loading control. One representative 
experiment from two performed is shown. Representation of the genomic organization of vSlfn 











Fig. S3. Absence of vSlfn in ECTV∆vSlfn does not affect viral replication. A) To analyze 
ECTV replication diverse types of cells were infected with the indicated viruses. Results showed 
that all recombinant viruses had similar kinetics of replication in vitro to ECTV-WT.  B) 
Similarly, ECTV replication in the presence or absence of vSlfn was analyzed in THP-1 cells and 
THP-1 cells lacking STING or cGAS expression. The multiplicity of infection of the viral 








Fig. S4. vSlfn prevents STING activation in response to cGAMP during ECTV infection. 
PMA-differentiated THP-1 cells were infected with 2 pfu/cell of the indicated viruses for 6 h 
before stimulation with cGAMP. Cell lysates were harvested at indicated times after cGAMP 
addition and analyzed by SDS-PAGE and immunoblotting with antibodies against the indicated 
proteins. The levels of cGAMP-induced STING dimerization as well as TBK1 and IRF3 
phosphorylation were reduced during ECTV-WT infection, but remained similar to those in 
mock-infected cells during ECTV∆vSlfn and ECTV-vSlfn∆p26 infection. D8 is an unrelated 







Fig. S5. Pathway enrichment analysis from DPLNs at 5 dpi. Similar to Fig. 4., DPLNs from 
ECTV-WT and ECTV∆vSlfn infected animals were collected at 5 dpi for RNA-sequencing and 
further differential expression analysis to compare wild type with ECTV∆vSlfn infection. 
Analysis of the corresponding differentially expressed genes revealed the enrichment of diverse 
pathways related to innate immunity (highlighted). Z-score values for activated (orange) or 












Fig. S6. Gating strategy for data in Fig. 6 and a representative example of each 
experimental condition are shown. The numbers of events positively stained in corresponding 
fluorescence minus one control samples were 0.069 % and 0.001 % positives in the case of 

















Table S1. Mortality rates of vSlfn recombinant ECTVs. Groups of 5 BALB/c mice were s.c. 
infected in the footpad with increasing doses of the indicated viruses and the number of survivors 
at 21 dpi determined for each condition are shown. Each column corresponds to an independent 





                           ECTV   
WT ∆vSlfn vSlfn∆p26 mSlfn1 mSlfn2 







n.d. n.d. n.d. n.d. 
10 0/5 5/5 n.d. n.d. n.d. n.d. n.d. 
102 n.d. 3/5 n.d. n.d. n.d. n.d. n.d. 
103 n.d. 5/5 5/5 5/5 4/5 5/5 5/5 
104 n.d. n.d. 5/5 5/5 n.d. 5/5 n.d. 
105 n.d. n.d. 5/5 5/5 n.d. 5/5 n.d. 




















































































































Expresses FLAG-tagged vSlfn optimized for 




Expresses FLAG-tagged vSlfn lacking p26 







Expresses FLAG-tagged vSlfn p26 domain 






Table S2. Vectors generated in the present work. Oligonucleotides used to generate the 
recombination vector together with the parental virus used in the construction of each 
recombinant mutant virus are detailed. Every recombination vector is based on previous pMS30. 
Below, mammalian expression vectors generated in this study and used in the reporter gene 
assays are shown. 
